Case 5-2010: A 51-year-old man with HIV infection, proteinuria, and edema

New England Journal of Medicine

Volumn 362, Issue 7, 2010, Pages 636-

  Radhakrishnan, Jai ^a   Uppot, Raul N ^b,c   Colvin, Robert B ^b,c  

^a NewYork Presbyterian Hospital   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMLODIPINE; ANTIRETROVIRUS AGENT; COLCHICINE; CYCLOPHOSPHAMIDE; EFAVIRENZ; EMTRICITABINE; FISH OIL; GLUTAMINE; IBUPROFEN; INDINAVIR; LISINOPRIL; LORATADINE; METHYLPREDNISOLONE; METOPROLOL; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PANTOPRAZOLE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RALTEGRAVIR; RIBAVIRIN; RITUXIMAB; TENOFOVIR; TRAZODONE; VARDENAFIL; VIRUS RNA;

ADULT; ALLERGY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; EDEMA; ELECTRON MICROSCOPY; FATTY LIVER; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; LIVER BIOPSY; MALE; NEPHROLITHIASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; ULTRASOUND; VASCULITIS; VIRUS LOAD; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; ECHOGRAPHY; GLOMERULUS; KIDNEY; METABOLIC SYNDROME X; MIDDLE AGED; PATHOLOGY;

DIAGNOSIS, DIFFERENTIAL; EDEMA; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEPATITIS C; HIV INFECTIONS; HUMANS; KIDNEY; KIDNEY GLOMERULUS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROTEINURIA;

EID: 77149134059     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc0910091     Document Type: Article

References (35)

1. Johnson RJ, Willson R, Yamabe H, et al. Renal manifestations of hepatitis C virus infection. Kidney Int 1994;46:1255-63.
2. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-70.
3. Roccatello D, Fornasieri A, Giachino O, et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 2007;49:69-82.
4. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
5. Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117:573-7.
6. Tarantino A, Campise M, Banfi G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995;47:618-23.
7. Stehman-Breen C, Alpers CE, Couser WG, Willson R, Johnson RJ. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 1995;44:141-7.
8. Cosio FG, Roche Z, Agarwal A, Falkenhain ME, Sedmak DD, Ferguson RM. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis 1996; 28:752-8.
9. Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D'Agati VD. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int 2003;63:1450-61.
10. Markowitz GS, Cheng JT, Colvin RB, Trebbin WM, D'Agati VD. Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 1998; 9:2244-52.
11. Carbone L, D'Agati V, Cheng JT, Appel GB. Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 1989;87:389-95.
12. Fine DM, Fogo AB, Alpers CE. Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient. Semin Nephrol 2008;28:545-55.
13. Estrella M, Fine DM, Gallant JE, et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clin Infect Dis 2006;43:377-80.
14. Soriano V, Puoti M, Sulkowski M, et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 2007;21:1073-89.
15. Cheng JT, Anderson HL Jr, Markowitz GS, Appel GB, Pogue VA, D'Agati VD. Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 1999;10:1566-74.
16. Warren GV, Korbet SM, Schwartz MM, Lewis EJ. Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs. Am J Kidney Dis 1989;13:127-30.
17. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001;59:1498-509.
18. Alpers CE, Kowalewska J. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 2008; 19:34-7.
19. Iskandar SS, Falk RJ, Jennette JC. Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 1992; 42:1401-7.
20. Bridoux F, Hugue V, Coldefy O, et al. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int 2002;62:1764-75.
21. Coroneos E, Truong L, Olivero J. Fibrillary glomerulonephritis associated with hepatitis C viral infection. Am J Kidney Dis 1997;29:132-5.
22. Guerra G, Narayan G, Rennke HG, Jaber BL. Crescentic fibrillary glomerulonephritis associated with hepatitis C viral infection. Clin Nephrol 2003;60:364-8.
23. Haas M, Rajaraman S, Ahuja T, Kittaka M, Cavallo T. Fibrillary/ immunotactoid glomerulonephritis in HIV-positive patients: a report of three cases. Nephrol Dial Transplant 2000;15:1679-83.
24. Ray S, Rouse K, Appis A, Novak R, Haller NA. Fibrillary glomerulonephritis with hepatitis C viral infection and hypocomplementemia. Ren Fail 2008;30:759-62.
25. Martin JL, Thomas D, Colindres RE. Immunotactoid glomerulopathy in an HIV-positive African-American man. Am J Kidney Dis 2003;42(6):E6-E10.
26. van Biljon G, Louw M, Dreyer L. Immunotactoid glomerulonephritis in a child with HIV infection: a case report. Pediatr Nephrol 2007;22:1387-90.
27. Yang GC, Nieto R, Stachura I, Gallo GR. Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the Congo rednegative amyloid-like fibrils of fibrillary glomerulopathy. Am J Pathol 1992;141: 409-19.
28. van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317:1554-7.
29. Rockstroh JK, Bhagani S, Benhamou Y, et al. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med 2008;9:82-8.
30. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl 2008;109:S1-S99.
31. D'Amico G, Ferrario F, Colasanti G, Bucci A. Glomerulonephritis in essential mixed cryoglobulinaemia. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985;21: 527-48.
32. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998;54: 650-71.
33. Saadoun D, Resche-Rigon M, Sene D, Perard L, Karras A, Cacoub P. Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis. Ann Rheum Dis 2008;67:1431-6.
34. Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 2003;101: 3818-26.
35. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008;3:25.